titanium dioxide used in medicine
In interior applications, titanium dioxide's non-toxic nature makes it suitable for use in areas with high human contact, such as homes and offices
China is a leading producer of titanium dioxide (TiO2), with a significant portion dedicated to the anatase type. This article delves into the qualities, production processes, and applications of high-purity anatase TiO2 from China, specifically focusing on the 99.6% variety.
Lithopone is an inorganic white pigment, obtained from co-precipitation of Zinc sulfide (ZnS) and Barium sulfate (BaSO4). As a white pigment, it acts as a cost-effective alternative for TiO2. Some of the properties of Lithopone include high brightness and performance under UV exposure. Lithopone requires less wetting agent to achieve optimum wetting of its surface. It is commercially graded on the basis of amount of ZnS. Its grades include 28%, 30%, and 60% ZnS. As a comparatively inexpensive white pigment, Lithopone is presently used in various paint formulations, road marking paints, jointing compounds, and putties.
In 2021, the European Food Safety Authority concluded that titanium dioxide is no longer safe in foods due to the same concerns over nanoparticles. As a result, titanium dioxide is now banned as a food additive in the EU. Although studies have shown that the absorption of ingested titanium dioxide is low, evidence suggests that titanium dioxide nanoparticles can accumulate in the body over time. Health Canada deemed it safe in 2022 but noted concerns. Unlike their European counterparts, Canadian officials did not consider studies performed with titanium dioxide nanoparticles alone.
In conclusion, the CaCO3 and TiO2 factory plays a vital role in supporting industrial and economic development by producing high-quality materials for a wide range of applications. The continued growth of industries such as construction, agriculture, and manufacturing relies on the availability of CaCO3 and TiO2 from reliable sources like the factory. As technology advances and demand increases, the factory will continue to innovate and expand its production capacity to meet the needs of a rapidly changing world.
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”